person · Reporting owner
SOBECKI CHRISTOPHER J
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,177 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 293,177 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WW INTERNATIONAL, INC.
Report date May 31, 2023 · Filed May 31, 2023
Section 16 reporting ended · disclosed 2023-05-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,954 |
Ending reported balance
After 2023-05-31 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-05-31 · Grant · Acquired 1,353 · Balance 107,901 Row 2 · 2023-05-31 · Exercise / conversion · Acquired 2,053 · Balance 109,954 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. |
| Deferred Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-05-31 · Exercise / conversion · Disposed 2,053 · Balance 0 F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement.
F2: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2026 Filed Jun 4, 2026 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000106 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 89,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 20:13 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 89,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000106 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 43,478 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001062822-26-000090 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,478 Underlying: Common Stock · 43,478 shares Expires 2036-05-01 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:57 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 35,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062822-26-000090 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,714 Underlying: Common Stock · 35,714 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 89,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-016473 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,312 Underlying: Common Stock · 89,312 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| June 03, 2025 Filed Jun 3, 2025 20:23 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 103,806 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001127602-25-016473 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,806 Underlying: Common Stock · 103,806 shares Expires 2035-06-03 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014144 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,810 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2025 Filed May 13, 2025 21:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 36,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-014144 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,865 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 36,810 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-015082 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,810 Underlying: Common Stock · 36,810 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 13, 2024 Filed May 13, 2024 20:03 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 44,906 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001127602-24-015082 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,906 Underlying: Common Stock · 44,906 shares Expires 2034-05-13 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 28, 2024 Filed Apr 29, 2024 20:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 8,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013557 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,032 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 28, 2024 Filed Apr 29, 2024 20:20 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 8,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-013557 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,055 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2023 Filed May 31, 2023 20:12 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | Exercise / conversionDeferred Stock Unit · Derivative | 2,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033104 · doc4.xml · derivative · entry 3 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,053 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units were settled into shares of Common Stock on May 31, 2023, the date of the Reporting Person's separation from service from the Issuer's Board of Directors, pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| May 31, 2023 Filed May 31, 2023 20:12 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | Exercise / conversionCommon Stock | 2,053 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-033104 · doc4.xml · nonDerivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. Read SEC document |
| May 31, 2023 Filed May 31, 2023 20:12 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 1,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033104 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,901 Read SEC document |
| May 21, 2023 Filed May 22, 2023 20:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016437 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2023 Filed May 22, 2023 20:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 9,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016437 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 12,658 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001127602-23-013788 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,658 Underlying: Common Stock · 12,658 shares Expires 2033-04-28 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:29 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 8,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013788 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,032 Underlying: Common Stock · 8,032 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 03, 2023 Filed Apr 5, 2023 20:09 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantDeferred Stock Unit · Derivative | 2,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023291 · doc4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,053 Underlying: Common Stock · 2,053 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Stock Unit represents a right to receive one share of Common Stock upon settlement. F2 · derivative.exercise_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the earlier of (i) August 15, 2028 (at which time, such shares of Common Stock will be subject to transfer restrictions) and (ii) the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. F2 · derivative.expiration_date: Pursuant to the Reporting Person's election, Deferred Stock Units will be settled into shares of Common Stock on the earlier of (i) August 15, 2028 (at which time, such shares of Common Stock will be subject to transfer restrictions) and (ii) the date of the Reporting Person's separation from service from the Issuer's Board of Directors pursuant to the deferred compensation program for non-employee members of the Issuer's Board of Directors. Read SEC document |
| January 02, 2023 Filed Jan 4, 2023 21:32 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 5,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-000960 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,548 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| November 17, 2022 Filed Nov 21, 2022 21:12 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | PurchaseCommon Stock | 30,000 | $4.17 | $125,124.00 |
DisclosureSEC source: 0001209191-22-058099 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,481 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.0554 to $4.2084, inclusive. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 21:36 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 4,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-052843 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,481 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| July 04, 2022 Filed Jul 6, 2022 20:40 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 2,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-041165 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,886 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015376 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015376 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012833 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:18 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012833 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:19 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 1,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-023472 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,141 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:20 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 1,179 | $15.90 | $18,746.10 |
DisclosureSEC source: 0001209191-22-001665 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,344 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 20:18 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 998 | $18.78 | $18,742.44 |
DisclosureSEC source: 0001209191-21-059828 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,165 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| July 05, 2021 Filed Jul 7, 2021 20:31 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 523 | $35.84 | $18,744.32 |
DisclosureSEC source: 0001209191-21-045811 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,167 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| July 01, 2021 Filed Jan 10, 2022 21:17 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GiftCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-001242 · form5.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,697 Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014973 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:07 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014973 · form4.xml · derivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014523 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:50 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014523 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2021 Filed Apr 7, 2021 20:36 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 609 | $30.77 | $18,738.93 |
DisclosureSEC source: 0001209191-21-025887 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,644 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:29 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002091 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,035 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 22:05 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 996 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-052501 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,311 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| June 29, 2020 Filed Jul 1, 2020 20:22 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-039745 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,315 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014570 · form4.xml · derivative · entry 4 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014570 · form4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014570 · form4.xml · derivative · entry 3 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638 Underlying: Common Stock · 10,638 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 18,115 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001127602-20-014570 · form4.xml · derivative · entry 2 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,115 Underlying: Common Stock · 18,115 shares Expires 2030-04-24 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 20:25 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 1,128 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022113 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,575 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 21:14 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 469 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-000267 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,447 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 21:03 UTC | WW INTERNATIONAL, INC. WW · Entity 6479 | GrantCommon Stock | 514 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051819 · doc4.xml · nonDerivative · entry 1 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,978 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 1,478 | $2.73 | $4,034.94 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 26 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,293 Read SEC document |
| September 16, 2019 Filed Sep 17, 2019 21:27 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | PurchaseCommon Stock | 3,700 | $2.75 | $10,175.00 |
DisclosureSEC source: 0001127602-19-028593 · form4.xml · nonDerivative · entry 25 SOBECKI CHRISTOPHER J · CIK 0001053892 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,815 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.